Breaking News Instant updates and real-time market news.

BBBY

Bed Bath & Beyond

$11.54

0.11 (0.96%)

08:34
07/11/19
07/11
08:34
07/11/19
08:34

Bed Bath & Beyond price target lowered to $13 from $18 at Baird

Baird analyst Peter Benedict lowered his price target for Bed Bath & Beyond to $13 from $18 and maintained a Neutral rating following the company's quarterly results. In a research note to investors, Benedict says that while adjusted EPS exceeded expectations, a lower tax rate/share count was required to offset an EBIT shortfall. While management remains focused on stabilizing sales in fiscal 2020, Benedict says he sees "little evidence" of an inflection on the horizon without sacrificing margins.

  • 25

    Jul

BBBY Bed Bath & Beyond
$11.54

0.11 (0.96%)

04/11/19
UBSW
04/11/19
NO CHANGE
Target $18
UBSW
Neutral
Bed Bath & Beyond price target raised to $18 from $13 at UBS
UBS analyst Michael Lasser raised his price target on Bed Bath & Beyond to $18 after its Q4 earnings beat but also kept his Neutral rating, questioning the management's announced strategy update. The analyst cites the company's plans to "cut back on couponing, lower marketing spend, reduce store labor, and make returns more stringent" as running "counter to what most retailers are doing currently" as they aim to capture more customers. Lasser adds that prioritizing profitability over sales has a "limited shelf life", and its current planned actions will make its low-single-digit long term sales growth objective "hard to achieve".
04/11/19
MSCO
04/11/19
NO CHANGE
Target $20
MSCO
Equal Weight
Bed Bath's weak Q1 view calls FY19 guidance into question, says Morgan Stanley
Morgan Stanley analyst Simeon Gutman said he is skeptical Bed Bath & Beyond will be able to deliver results in line with its "overly optimistic" 2019 guidance given the company's weak Q1 outlook. He also questions the achievability of the company's "bullish" long-term guidance as he expects macroeconomic pressure and competitive headwinds to intensify. Gutman added that he believes Bed Bath's intention to accelerate its board refreshment process may not suffice and that the company could be headed towards a proxy fight with the activists that are involved in the stock. He keeps an Equal Weight rating and $20 price target on Bed Bath & Beyond shares.
07/09/19
LOOP
07/09/19
NO CHANGE
Target $12
LOOP
Hold
Bed Bath & Beyond price target lowered to $12 from $16 at Loop Capital
Loop Capital analyst Anthony Chukumba lowered his price target on Bed Bath & Beyond (BBBY) to $12 to reflect the "uncertainty" surrounding the company's management team and turnaround strategy, even though the most recent pricing study relative to Amazon (AMZN) saw a slight narrowing in pricing average to 10.6% from 12.5% premium in April. The analyst also maintains a Hold rating on Bed Bath & Beyond, saying the company has a long road ahead to reverse its long string of fundamental underperformance.
07/11/19
GSCO
07/11/19
INITIATION
Target $11
GSCO
Sell
Bed Bath & Beyond initiated with a Sell at Goldman Sachs
Goldman Sachs analyst Kate McShane started Bed Bath & Beyond with a Sell rating and $11 price target. Weak in-store trends and over-reliance on coupons as a traffic driver have led to significant pressure on sales and margins, McShane tells investors in a research note. She expects expect Bed Bath & Beyond will face ongoing sales declines and market share losses resulting from a high level of competition in the industry and continued challenges with its store fleet.

TODAY'S FREE FLY STORIES

MU

Micron

$47.02

1.51 (3.32%)

, TSLA

Tesla

$256.90

-1.22 (-0.47%)

11:45
07/22/19
07/22
11:45
07/22/19
11:45
On The Fly
Micron upgrade, Tesla downgrade among today's top analyst calls »

Check out today's top…

MU

Micron

$47.02

1.51 (3.32%)

TSLA

Tesla

$256.90

-1.22 (-0.47%)

SFIX

Stitch Fix

$27.18

0.27 (1.00%)

NDAQ

Nasdaq

$101.74

0.02 (0.02%)

ICE

IntercontinentalExchange

$90.40

-0.34 (-0.37%)

AAPL

Apple

$206.04

3.42 (1.69%)

UBER

Uber

$43.60

0.42 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 24

    Jul

  • 30

    Jul

  • 01

    Aug

  • 03

    Aug

  • 06

    Aug

  • 06

    Aug

  • 08

    Aug

APRN

Blue Apron

$8.93

0.58 (6.95%)

11:45
07/22/19
07/22
11:45
07/22/19
11:45
Options
Blue Apron call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

CARA

Cara Therapeutics

$25.78

-0.13 (-0.50%)

11:42
07/22/19
07/22
11:42
07/22/19
11:42
Recommendations
Cara Therapeutics analyst commentary  »

Cara Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:36
07/22/19
07/22
11:36
07/22/19
11:36
General news
6-Month Bill Auction Total Amount data reported »

6-Month Bill Auction…

11:36
07/22/19
07/22
11:36
07/22/19
11:36
General news
3-Month Bill Auction Total Amount data reported »

3-Month Bill Auction…

MRNA

Moderna

$14.03

-0.07 (-0.50%)

11:34
07/22/19
07/22
11:34
07/22/19
11:34
Conference/Events
Moderna management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jul

  • 30

    Jul

  • 09

    Sep

DIOD

Diodes

$37.88

0.44 (1.18%)

11:28
07/22/19
07/22
11:28
07/22/19
11:28
Periodicals
Diodes mentioned cautiously by 'Cold Shower Analytics' 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Aug

CRON

Cronos Group

$14.55

-0.41 (-2.74%)

11:25
07/22/19
07/22
11:25
07/22/19
11:25
Options
Cronos Group call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

MDWD

MediWound

$3.76

0.04 (1.08%)

11:25
07/22/19
07/22
11:25
07/22/19
11:25
Conference/Events
MediWound to host analyst day »

Analyst day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

11:25
07/22/19
07/22
11:25
07/22/19
11:25
Conference/Events
The Board of Governors of the Federal Reserve System to hold a meeting »

Closed Board Meeting to…

GIS

General Mills

$52.28

-0.5 (-0.95%)

, DNKN

Dunkin' Brands

$79.45

-0.63 (-0.79%)

11:19
07/22/19
07/22
11:19
07/22/19
11:19
Hot Stocks
Dunkin' Brands appoints Stephanie Lilak as Chief Human Resources Officer »

Dunkin' Brands…

GIS

General Mills

$52.28

-0.5 (-0.95%)

DNKN

Dunkin' Brands

$79.45

-0.63 (-0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
07/22/19
07/22
11:17
07/22/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
07/22/19
07/22
11:16
07/22/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIO

Rio Tinto

$60.52

-0.6 (-0.98%)

11:15
07/22/19
07/22
11:15
07/22/19
11:15
Options
Rio Tinto put volume heavy and directionally bearish »

Bearish flow noted in Rio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

11:15
07/22/19
07/22
11:15
07/22/19
11:15
General news
FX Action: USD-JPY »

FX Action: USD-JPY traded…

11:15
07/22/19
07/22
11:15
07/22/19
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

11:15
07/22/19
07/22
11:15
07/22/19
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

NTEC

Intec Pharma

$0.47

-2.5179 (-84.21%)

11:11
07/22/19
07/22
11:11
07/22/19
11:11
Downgrade
Intec Pharma rating change  »

Intec Pharma downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTC

MMTEC

$17.20

0.1 (0.58%)

11:11
07/22/19
07/22
11:11
07/22/19
11:11
Hot Stocks
Breaking Hot Stocks news story on MMTEC 

MMTec Inc trading resumes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOSBF

Toshiba, also use TOSYY

$0.00

(0.00%)

, TOSYY

Toshiba, also use TOSBF

$0.00

(0.00%)

11:07
07/22/19
07/22
11:07
07/22/19
11:07
On The Fly
Micron rises as Goldman Sachs gets more positive on memory stocks, says Buy »

Shares of Micron (MU) are…

TOSBF

Toshiba, also use TOSYY

$0.00

(0.00%)

TOSYY

Toshiba, also use TOSBF

$0.00

(0.00%)

MU

Micron

$46.74

1.23 (2.70%)

MRVL

Marvell

$25.86

-0.04 (-0.15%)

AMAT

Applied Materials

$49.94

2.15 (4.50%)

LRCX

Lam Research

$205.90

7.47 (3.76%)

KLAC

KLA-Tencor

$134.27

2.32 (1.76%)

KEYS

Keysight Technologies

$87.03

-0.4 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 05

    Aug

DRRX

Durect

$0.86

0.1336 (18.46%)

, GILD

Gilead

$64.87

-0.17 (-0.26%)

11:05
07/22/19
07/22
11:05
07/22/19
11:05
Recommendations
Durect, Gilead analyst commentary at H.C. Wainwright »

Gilead pact offers…

DRRX

Durect

$0.86

0.1336 (18.46%)

GILD

Gilead

$64.87

-0.17 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 30

    Jul

  • 07

    Aug

  • 09

    Sep

AG

First Majestic

$10.17

0.27 (2.73%)

11:05
07/22/19
07/22
11:05
07/22/19
11:05
Options
First Majestic call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GILD

Gilead

$64.98

-0.06 (-0.09%)

11:03
07/22/19
07/22
11:03
07/22/19
11:03
Hot Stocks
Gilead presents proof-of-concept data for GS-6207 in people living with HIV »

Gilead Sciences presented…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 30

    Jul

  • 07

    Aug

  • 09

    Sep

USB

U.S. Bancorp

$55.12

0.135 (0.25%)

, BMWYY

BMW

$0.00

(0.00%)

11:02
07/22/19
07/22
11:02
07/22/19
11:02
Hot Stocks
U.S. Bank enters co-brand agreement with BMW to issue new cards »

U.S. Bank (USB) has…

USB

U.S. Bancorp

$55.12

0.135 (0.25%)

BMWYY

BMW

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 16

    Oct

TPGH

TPG Pace

$10.33

(0.00%)

11:01
07/22/19
07/22
11:01
07/22/19
11:01
Conference/Events
TPG Pace management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 26

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.